ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Pneumonia
Post-Acute COVID-19 Syndrome
Respiratory Distress Syndrome

COVID-19 trials near Philadelphia, PA, USA:

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...

Enrolling
COVID-19
Biological: CVXGA (CVXGA50)
Biological: COMIRNATY®

Phase 2

Cyanvac

Philadelphia, Pennsylvania, United States and 54 other locations

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting
COVID-19
Biological: mRNA-1283.222
Biological: mRNA-1273.815

Phase 3

Moderna
Moderna

Philadelphia, Pennsylvania, United States and 217 other locations

(SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID...

Enrolling
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: COMIRNATY®

Phase 2

Vaxart

Media, Pennsylvania, United States and 144 other locations

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.This study is seeking healthy...

Enrolling
COVID-19 (Coronavirus Disease 2019)
Influenza
Combination Product: Investigational Influenza and COVID-19 Combination Vaccine
Biological: Investigational COVID-19 Vaccine

Phase 1, Phase 2

BioNTech
BioNTech

Philadelphia, Pennsylvania, United States and 25 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Philadelphia, Pennsylvania, United States and 66 other locations

Status recently updated

The purpose of this study is to evaluate the immunogenicity, reactogenicity, and safety, of mRNA-1083 multicomponent influenza and COVID-19...

Not yet enrolling
Enrolling
Influenza
SARS-CoV-2
Biological: COVID-19 Vaccine
Biological: Investigational COVID-19 Vaccine Lot B

Phase 2

Moderna
Moderna

Philadelphia, Pennsylvania, United States and 16 other locations

the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...

Enrolling
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Philadelphia, Pennsylvania, United States and 31 other locations

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Biological: Intramuscular vaccine
Drug: Intramuscular injection

Phase 2, Phase 3

Medicago

Berlin, New Jersey, United States of America and 90 other locations

doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome (post-Coronavirus Disease 2019 \[COVID...

Enrolling
Post-COVID Postural Orthostatic Tachycardia Syndrome
Biological: IgPro20
Biological: Placebo

Phase 3

CSL Behring
CSL Behring

Philadelphia, Pennsylvania, United States and 35 other locations

The COVID-19 VaccinE Response in Rheumatology patients (COVER) study is a multicenter randomized controlled trial designed to evalu-...

Enrolling
Psoriatic Arthritis
Spondylarthritis
Drug: Abatacept
Drug: Baricitinib

Phase 4

Jeffrey Curtis

Philadelphia, Pennsylvania, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems